Dr. Adler received his M.D. and Ph.D. (pharmacology) from NYU School of Medicine and did his neurology residency and movement disorders fellowship at the University of Pennsylvania. He then joined Mayo Clinic Arizona with research interests in biomarkers for an early diagnosis of Parkinson’s disease and PD with dementia, identifying new treatments for PD and other movement disorders, and studying sports neurology including golfer’s cramp (yips) and biomarkers for chronic traumatic encephalopathy. Dr. Adler was awarded the 2006 Distinguished Investigator of the Year Award at Mayo Clinic Arizona.
Tim Ahles, Ph.D. is the Director of the Neurocognitive Research Laboratory at Memorial Sloan-Kettering Cancer Center. Over the last 20 years, his research has focused on cognitive side effects of cancer treatments including chemotherapy, hormonal therapy, and radiation therapy. These studies have included cross-sectional and longitudinal studies of chemotherapy-induced cognitive change utilizing neuropsychological assessments and structural and functional MRI, examination of genetic other biological factors that increase risk for cognitive changes, study of the interface of treatment-induced cognitive change and ageing, and the evaluation of cognitive behavioral interventions.
Contact Dr. Ahles at: email@example.com
Dr. Bernick graduated summa cum laude from Rice University with a BA in history, received his MD from University of Texas Southwestern, and was elected to the medical honor society, alpha omega alpha. Dr. Bernick completed a neurology residency at the University of Miami, followed by a neurology fellowship at the University of Arizona, and a Masters of Public Health at the University of Nevada, Las Vegas. He is currently Associate Director of the Cleveland Clinic Lou Ruvo Center for Brain Health and directs the Professional Fighters Brain Health study, which aims to understand the effects of cumulative head trauma on the brain.
Contact Dr. Bernick at: BERNICC@ccf.org
Russell T. Joffe, M.D., is a Professor of Psychiatry at Hofstra LIJ-North Shore School of Medicine. Previously he held senior administrative and clinical research positions in the United States and Canada. He has been consistently funded by peer-reviewed government and private agencies in these two countries. He has more than 400 peer reviewed publications and abstracts and more than 35 book chapters. His research interests are the pharmacology of treatment-resistant depression, bipolar disorder and the role of thyroid hormones in mood and cognition.
Contact Dr. Joffe at: firstname.lastname@example.org
Dr. Mandelblatt is the Associate Director for Population Sciences at Lombardi Comprehensive Cancer Center and a tenured Professor of Medicine and Oncology at Georgetown University. Dr. Mandelblatt is one of a limited number of US scientists conducting research at the intersection of cancer and aging. She currently serves as the lead of the NCI's Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Working Group and has led breast cancer screening analyses for the Centers for Disease Control and Prevention, the American Cancer Society, and the US Preventive Services Task Force.
Contact Dr. Mandelblatt at: email@example.com
Lisa earned a BA from Cornell University where she met her husband, Tom McHale, an All-American Defensive End for the Big Red. They married and moved to Tampa, where Tom began his NFL career and Lisa received degrees in School Psychology from the University of South Florida. When Tom passed away in 2008, Lisa donated his brain to the VA-BU-SLI brain bank where he was diagnosed with CTE. In 2010, Lisa joined the Sports Legacy Institute as Director of Family Relations, serving as the liaison between the researchers and donor families.
Contact Lisa at: firstname.lastname@example.org
Dr. Pasquale is Professor of Ophthalmology at Mass Eye and Ear where he is Director of the Glaucoma Service and co-Director of the Harvard Glaucoma Center of Excellence. His has produced seminal work demonstrating that systemic endothelial cell dysfunction contributes to the pathogenesis of primary open-angle glaucoma. His research interest centers on the discovery of gene-environment interactions in the open-angle glaucomas.
Contact Dr. Pasquale at: Louis_Pasquale@meei.harvard.edu
Dr. Martha E. Shenton is Professor of Psychiatry and Radiology, and Director of the Psychiatry Neuroimaging Laboratory, Brigham and Women’s Hospital, Harvard Medical School. She is also a Health Scientist at the VA Boston Healthcare System. Her laboratory has pioneered in development of neuroimaging tools to understand brain alterations in disorders such as schizophrenia, traumatic brain injury – including sports-related brain trauma – posttraumatic stress disorder, William’s syndrome, and Velocardiofacial Syndrome. She received her A.B. degree in Psychology from Wellesley College and her Ph.D. in Psychology from Harvard University.
Learn more HERE
Contact Dr. Shenton at: email@example.com